Clinical Trials on Sjögren

Total 142 results

University of Nebraska

Completed

Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers (SLS)

Sjogren-Larsson Syndrome (SLS)

United States
Rise Therapeutics LLC

Not yet recruiting

R-2487 in Patients With Sjogren's Syndrome (SS) (R-2487-SS-01)

Sjogren's Syndrome | Sjögren | Sjögren Syndrome, Unspecified
Akdeniz University

Completed

Pelvic Floor Exercises in Patients With Sjögren's

Sjögren Syndrome | Sjögren

Turkey
Pontificia Universidad Catolica de Chile
Formulario MAgistral Farmacias Ahumada

Completed

A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment

Xerostomia | Primary Sjogren | Secondary Sjogren

Chile
Aldeyra Therapeutics, Inc.

Completed

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Sjogren-Larsson Syndrome

United States
Region Skane

Completed

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response (Vaccimil)

Syndrome | Vasculitis | SLE | Scleroderma | RA | Sjögrens

Sweden
Aldeyra Therapeutics, Inc.

Completed

A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)

Sjögren-Larsson Syndrome

United States
Federal University of São Paulo
Allergan

Completed

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

Evaporative Dry Eye Disease | Primary Sjogren Syndrome | Secondary Sjogren Syndrome | Aqueous Deficient Dry Eye Disease

Brazil
Peking Union Medical College Hospital

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
University Hospital, Brest

Completed

Ultrasound Elastography of Salivary Glands (ELSA)

sjögren Disease

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Dental and Periodontal Status of Patients With Sjögren's Syndrome. (CB-SJO)

Sjögren Syndrome

France
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Primary Sjögren Syndrome

China
University of Rochester
Janssen, LP

Completed

Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome

Primary Sjögren Syndrome

United States
University of Copenhagen
Rigshospitalet, Denmark; ITI Foundation; Gigtforeningen

Completed

Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome

Dental Implant | Primary Sjögren Syndrome
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)

Sjögren Syndrome

United States, United Kingdom, Netherlands, Australia, Austria, Israel, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Japan, Portugal, Russian Federation, Turkey, Canada, Colombia, Romania, Argentina, Chile, Brazil, S...
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
Ankara Education and Research Hospital

Completed

Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions

Primary Sjögren Syndrome

Turkey
University Hospital, Brest

Unknown

Eye Dryness Evaluation in Primary Sjögren's Syndrome (PEPSS)

Primary Sjögren Syndrome
Federal University of São Paulo

Completed

Resistance Exercise in Woman With Primary Sjörgen Syndrome.

Primary Sjögren Syndrome
Charite University, Berlin, Germany

Completed

Low Dose Cyclosporin A in Primary Sjögren Syndrome (CYPRESS)

Sjögren´s Syndrome

Germany
Resolve Therapeutics

Not yet recruiting

A Phase 2 Study of RSLV-132 in Females With Primary Sjögren's Syndrome

Primary Sjögren Syndrome
University of Sao Paulo General Hospital

Active, not recruiting

N-acetylcysteine for Primary Sjögren's Syndrome (NACSS)

Sicca Syndrome | Sjögren Syndrome

Brazil
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Unither Pharmaceuticals, France

Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NIAGARA)

Head and Neck Cancer | Xerostomia | Hyposalivation | Sjögren Syndrome

France
University Hospital, Brest

Unknown

Inflammatory Myopathies in Primary Sjögren's Syndrome (AMISS)

Primary Sjögren Syndrome

France
Hospital Nacional Profesor Alejandro Posadas

Completed

Comparison Between Rebamipide 2% Versus Autologous Serum

Dry Eye Syndromes | Sjögren Syndrome

Argentina
Santen Pharmaceutical(China) Co.,LTD

Completed

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

Dry Eye Syndromes | Sjögren Syndrome

China
Marmara University

Completed

Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome

Small Fiber Neuropathy | Primary Sjögren Syndrome

Turkey
Helse Stavanger HF
University of Oslo; University of Stavanger

Completed

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome

Fatigue | Primary Sjogren

Norway
TearSolutions, Inc.

Completed

Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome

Dry Eye | Primary Sjögren Syndrome

United States
University of Roma La Sapienza

Unknown

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction (SPEEDCARS)

Sjogren Syndrome

Italy
Dompé Farmaceutici S.p.A

Recruiting

Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye (GEMINAE)

Dry Eye | Sjögren Syndrome

United States
NHS Greater Glasgow and Clyde
Glasgow Caledonian University; Lamellar Biomedical Ltd; Robertson Centre for...

Unknown

LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients

Dry Eye Syndromes | Primary Sjögren Syndrome
University Hospital, Montpellier

Recruiting

Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis (CIRCEE)

Primary Gougerot-Sjögren Syndrome | Systemic Sclerosis, Diffuse

France
University Hospital, Montpellier

Completed

Vaccine Coverage and Primary Sjögren'Syndrome (VACGREN)

Primary Sjögren Syndrome

France
Novartis Pharmaceuticals

Active, not recruiting

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Sjogren Syndrome

United States, Turkey, Belgium, Austria, Spain, France, Germany, Korea, Republic of, Guatemala, Portugal, China, Singapore, Brazil, Czechia, Chile, Poland, Mexico, Lithuania
Augusta University
GlaxoSmithKline

Completed

Green Tea Lozenges for the Management of Dry Mouth

Xerostomia | Sjogren Syndrome | Dry Mouth

United States
IRCCS Burlo Garofolo

Recruiting

Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease

Sjögren | Autoimmune Thyroid Disease

Italy
Sylentis, S.A.

Completed

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

Dry Eye Disease | Sjögren Syndrome

United States, Spain
Novartis Pharmaceuticals

Recruiting

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Sjogren Syndrome

Spain, Hungary, Germany, Canada, Greece, Bulgaria, Japan, Colombia, United States, South Africa, Australia, China, Mexico, Israel, Lebanon, Taiwan, Italy, Argentina, France, Chile, Romania, United Kingdom, India, Brazil, Poland, Slovakia, S...
Novartis Pharmaceuticals

Active, not recruiting

Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.

Sjogren Syndrome

France
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
Ankara City Hospital Bilkent

Completed

Sjögren and Gynecologic Considerations

Sexual Dysfunction | Vaginitis | Primary Sjögren Syndrome | Vaginitis Candida

Turkey
Novartis Pharmaceuticals

Not yet recruiting

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Sjögrens Disease
Novartis Pharmaceuticals

Terminated

A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

Sjogren Syndrome | Mixed Connective Tissue Disease

Spain, Hungary, Germany, China, Poland, Taiwan
Assistance Publique - Hôpitaux de Paris
LFB BIOMEDICAMENTS

Recruiting

Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy (SFINESS-QoLEco)

Quality of Life | Small Fiber Neuropathy | Primary Sjögren Syndrome | Medico-economic Impact

France
National Council of Scientific and Technical Research...

Unknown

Biomarkers in Primary Sjögren's Syndrome (pSS)

Lymphoma, Non-Hodgkin | Primary Sjögren Syndrome
Novartis Pharmaceuticals

Not yet recruiting

Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases

Systemic Lupus Erythematosus | Sjogren Disease
Universidad Nacional de Colombia

Completed

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

Dry Eye | Sjogren Syndrome

Clinical Trials on Sjögren

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations